AU2019378162B2 - Peptides and pharmaceutical compositions for treating eye diseases - Google Patents

Peptides and pharmaceutical compositions for treating eye diseases Download PDF

Info

Publication number
AU2019378162B2
AU2019378162B2 AU2019378162A AU2019378162A AU2019378162B2 AU 2019378162 B2 AU2019378162 B2 AU 2019378162B2 AU 2019378162 A AU2019378162 A AU 2019378162A AU 2019378162 A AU2019378162 A AU 2019378162A AU 2019378162 B2 AU2019378162 B2 AU 2019378162B2
Authority
AU
Australia
Prior art keywords
yde
concentration
gly
dose response
hyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019378162A
Other languages
English (en)
Other versions
AU2019378162A1 (en
Inventor
Taegon Baik
Jong-Yun Choi
Gyoung-Wook MIN
Chun Ho Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of AU2019378162A1 publication Critical patent/AU2019378162A1/en
Application granted granted Critical
Publication of AU2019378162B2 publication Critical patent/AU2019378162B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2019378162A 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases Active AU2019378162B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
US62/767,180 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Publications (2)

Publication Number Publication Date
AU2019378162A1 AU2019378162A1 (en) 2021-05-20
AU2019378162B2 true AU2019378162B2 (en) 2025-01-30

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019378162A Active AU2019378162B2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Country Status (10)

Country Link
EP (1) EP3880690A4 (https=)
JP (1) JP7522732B2 (https=)
KR (1) KR20210087539A (https=)
CN (1) CN113474356B (https=)
AU (1) AU2019378162B2 (https=)
BR (1) BR112021009341A2 (https=)
MX (1) MX2021005077A (https=)
SG (1) SG11202104178TA (https=)
TW (1) TWI865470B (https=)
WO (1) WO2020099925A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
CA3170606A1 (en) * 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
KR101690539B1 (ko) * 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Also Published As

Publication number Publication date
WO2020099925A3 (en) 2020-06-25
WO2020099925A2 (en) 2020-05-22
JP7522732B2 (ja) 2024-07-25
CN113474356B (zh) 2024-12-17
SG11202104178TA (en) 2021-05-28
JP2022507404A (ja) 2022-01-18
EP3880690A4 (en) 2023-09-13
EP3880690A2 (en) 2021-09-22
CA3119921A1 (en) 2020-05-22
CN113474356A (zh) 2021-10-01
MX2021005077A (es) 2021-08-11
KR20210087539A (ko) 2021-07-12
AU2019378162A1 (en) 2021-05-20
TW202031675A (zh) 2020-09-01
TWI865470B (zh) 2024-12-11
BR112021009341A2 (pt) 2021-08-10

Similar Documents

Publication Publication Date Title
AU2019378162B2 (en) Peptides and pharmaceutical compositions for treating eye diseases
JP7775250B2 (ja) 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
CA2746264C (en) New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
CA2657618A1 (en) 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
US20230146455A1 (en) Treatment of inflammatory diseases with peptides and pharmaceutical compositions
US20230312648A1 (en) Peptides and pharmaceutical compositions for treating eye diseases
RU2819399C2 (ru) Пептиды и фармацевтические композиции для лечения глазных болезней
CA3119921C (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40061089A (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40061089B (zh) 用於治疗眼病的肽和药物组合物
HK40017864A (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
MX2011003259A (es) Compuesto de peptido y metodo para producir el mismo.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)